Invention Grant
- Patent Title: Substituted benzenesulfonamides as inhibitors of alpha-4 beta-7 integrin activity
-
Application No.: US16075415Application Date: 2017-02-06
-
Publication No.: US10562898B2Publication Date: 2020-02-18
- Inventor: Munetaka Tokumasu , Masatsugu Noguchi , Mizuki Kawahira , Kana Iwasaki , Nobuhiko Hayakawa , Wataru Miyanaga , Yuki Saitou , Yui Yamaura , Ayatoshi Ando , Atsushi Tsuruta , Misato Noguchi
- Applicant: EA PHARMA CO., LTD.
- Applicant Address: JP Chuo-ku
- Assignee: EA PHARMA CO., LTD.
- Current Assignee: EA PHARMA CO., LTD.
- Current Assignee Address: JP Chuo-ku
- Agency: Oblon, McClelland, Maier & Neustadt, L.L.P.
- Priority: JP2016-021053 20160205
- International Application: PCT/JP2017/004278 WO 20170206
- International Announcement: WO2017/135472 WO 20170810
- Main IPC: A61K31/18
- IPC: A61K31/18 ; C07D307/02 ; C07D471/04 ; C07D401/14 ; C07D405/14 ; C07D401/04 ; C07D401/12 ; C07D405/12 ; C07D239/54 ; C07D409/12 ; C07D491/052 ; A61P1/00 ; C07D473/04
Abstract:
Provided is a compound having α4 integrin inhibitory action.The compound is a sulfonamide derivative represented by the following formula (I), or pharmaceutically acceptable salt thereof: where R1 to R5, e to h, D, and B represent those as described in the specification.
Public/Granted literature
- US20190040059A1 SULFONAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME Public/Granted day:2019-02-07
Information query
